|
Volumn 26, Issue 5, 2002, Pages 451-457
|
C/EBP-β, C/EBP-δ, PU.1, AML1 genes: Mutational analysis in 381 samples of hematopoietic and solid malignancies
|
Author keywords
AML1; C EBP ; C EBP ; Cancer; Mutations; PU.1
|
Indexed keywords
CCAAT ENHANCER BINDING PROTEIN;
CCAAT ENHANCER BINDING PROTEIN BETA;
CCAAT ENHANCER BINDING PROTEIN DELTA;
GENOMIC DNA;
TRANSCRIPTION FACTOR PU 1;
TRANSCRIPTION FACTOR RUNX1;
UNCLASSIFIED DRUG;
ARTICLE;
BURKITT LYMPHOMA;
CANCER CELL CULTURE;
CHRONIC MYELOID LEUKEMIA;
CODON;
CONTROLLED STUDY;
DNA SEQUENCE;
EXON;
GENE MUTATION;
HUMAN;
HUMAN CELL;
MAJOR CLINICAL STUDY;
MISSENSE MUTATION;
MUTATIONAL ANALYSIS;
PATHOGENESIS;
PRIORITY JOURNAL;
SEQUENCE ANALYSIS;
SILENT GENE;
SINGLE STRAND CONFORMATION POLYMORPHISM;
SOLID TUMOR;
CCAAT-ENHANCER-BINDING PROTEIN-BETA;
CCAAT-ENHANCER-BINDING PROTEIN-DELTA;
CCAAT-ENHANCER-BINDING PROTEINS;
CORE BINDING FACTOR ALPHA 2 SUBUNIT;
DNA-BINDING PROTEINS;
HEMATOLOGIC NEOPLASMS;
HUMANS;
MUTATION;
NEOPLASMS;
PROTO-ONCOGENE PROTEINS;
TRANS-ACTIVATORS;
TRANSCRIPTION FACTORS;
|
EID: 18344372734
PISSN: 01452126
EISSN: None
Source Type: Journal
DOI: 10.1016/S0145-2126(01)00150-3 Document Type: Article |
Times cited : (50)
|
References (30)
|